| Literature DB >> 32456642 |
Mohammad Khani1, Ahmad Tara1, Shadi Shekarkhar2, Morteza Abdar Esfahani3, Fariba Bayat1.
Abstract
BACKGROUND: Advanced chronic kidney disease often results in adverse cardiovascular outcomes and is the leading cause of mortality in patients with end stage renal diseases (ESRD). There is much information about the effect of chronic kidney diseases (CKD) on the left ventricle (LV) chamber, but the right ventricle (RV) as a neglected chamber had not been evaluated precisely, in spite of its importance.Entities:
Keywords: 2-D speckle tracking echocardiography; Kidney transplant
Mesh:
Year: 2020 PMID: 32456642 PMCID: PMC7251705 DOI: 10.1186/s12947-020-00200-7
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
The prevalence and changes of IVC size and respiratory collapsibility before and after kidney transplant over the time
| Before transplant | One week after transplant | One month after transplant | 3 months after transplant | Mean square | F | ||
|---|---|---|---|---|---|---|---|
| IVC < 21 mm | 83.3% | 87.5% | 89.6% | 92.9% | 0.085 | 0.851 | 0.451 |
| Respiratory collapse≥50% | 91.7% | 95.8% | 91.7% | 97.6% | 0.849 | 0.480 | 0.508 |
Basic and demographic data of the participants according to their gender
| Variables | Category | Male ( | Female ( | Total population | |
|---|---|---|---|---|---|
| Mean (SD)/num (%) | Mean (SD)/num (%) | ||||
| Age | Year | 43.8 ± 14 | 42.6 ± 14.1 | 43.5 ± 13.9 | 0.79 |
| BMI | (kg/m2) | 23.7 ± 3.9 | 26.1 ± 7.3 | 24.7 ± 5.7 | 0.13 |
| Phosphor | 5.71 ± 1.41 | 5.95 ± 1.29 | 5.81 ± 1.35 | 0.56 | |
| Creatinine | 8.18 ± 3.0 | 7.71 ± 2.67 | 7.99 ± 2.88 | 0.57 | |
| Calcium | 8.77 ± 1.0 | 7.9 ± 1.15 | 8.42 ± 1.17 | 0.012 | |
| Ferritin | 61.6 ± 34.4 | 49.6 ± 25.8 | 56.6 ± 31.4 | 0.19 | |
| Urea | 113.5 ± 40.1 | 115.9 ± 41.6 | 114.5 ± 40.3 | 0.84 | |
| Hemoglobin | 11 ± 2.0 | 10.1 ± 2.0 | 10.6 ± 2.0 | 0.16 | |
| Duration of dialysis | pre-emptive | 3 (10.7) | 3 (15) | 6 (12.5) | 0.48 |
| < 6 months | 4 (14.3) | 6 (30) | 10 (20.83) | ||
| 6–12 months | 6 (21.4) | 4 (20) | 10 (20.83) | ||
| > 12 months | 15 (53.6) | 7 (35) | 20 (45.83) | ||
| Dialysis type | pre-emptive | 3 (10.7) | 3 (15) | 6 (12.5) | 0.55 |
| Hemodialysis | 21 (75) | 16 (80) | 37 (77.08) | ||
| Peritoneal dialysis | 4 (14.3) | 1 (5) | 5 (10.42) | ||
| Diabetes | Yes | 6 (21.4) | 5 (25) | 11 (22.92) | 0.77 |
| Hypertension | Yes | 19 (70.4) | 12 (60) | 31 (65.96) | 0.45 |
| Smoking | Yes | 4 (14.3) | 0 (0) | 4 (8.33) | 0.07 |
1value is presented as mean ± SD or n. (%) compared using independent T-test or chi square test, respectively
Changes of recommended measures of left ventricle in 48 studied participants over the time
| LV function indices | Before transplant | One week after transplant | One month after transplant | 3 months after transplant | Mean square | F | |
|---|---|---|---|---|---|---|---|
| LA volume index | 31.27 ± 5.5 | 30.89 ± 4.6 | 29.27 ± 3.5 | 26.69 ± 3.6 | 200.31 | 15.2 | 0.000 |
| LVEDV | 96.8 ± 12 | 102.18 ± 13 | 103.95 ± 9.8 | 96.54 ± 8.8 | 804.79 | 6.4 | 0.001 |
| LVEF | 58.53 ± 5.7 | 56.19 ± 7.3 | 57 ± 7.3 | 58.5 ± 4.3 | 42.12 | 1.79 | 0.166 |
| CO/index | 3.05 ± 48 | 3.22 ± 0.54 | 3.5 ± 0.40 | 3.44 ± 0.47 | 1.59 | 6.25 | 0.001 |
| E/e | 0.78 ± 0.20 | 0.76 ± 0.20 | 0.86 ± 0.22 | 0.92 ± 0.24 | 0.241 | 5.94 | 0.002 |
Changes of the recommended measures of right heart structure and function in 48 studied participants over the time
| RV function indices | Before transplant | One week after transplant | One month after transplant | 3 months after transplant | Mean square | F | |
|---|---|---|---|---|---|---|---|
| RV thickness (mm) | 5.16 ± 0.99 | 5.21 ± 1.09 | 4.91 ± 1.31 | 5.1 ± 0.96 | 0.604 | 0.376 | 0.62 |
| RV global longitudinal strain | −16.6 ± 5.8 | −17.9 ± 5.0 | −18.9 ± 5.54 | −19.9 ± 4.8 | 107.2 | 3.85 | 0.024 |
| RV free wall longitudinal strain | −21.2 ± 5.2 | − 23.1 ± 5.0 | −24.4 ± 5.3 | −26.3 ± 11 | 493.7 | 6.74 | < 0.001 |
| RV basal diameter (mm) | 33.3 ± 5.7 | 29.2 ± 4.1 | 25.2 ± 1.6 | 25.5 ± 4.0 | 82.3 | 4.78 | 0.007 |
| RV mid cavity diameter (mm) | 26.6 ± 4.9 | 26.5 ± 5.7 | 26.2 ± 4.4 | 23.6 ± 2.8 | 30.9 | 1.54 | 0.22 |
| RV longitudinal diameter (mm) | 61.9 ± 14.6 | 60.5 ± 15.2 | 54.5 ± 5.9 | 51.6 ± 3.8 | 342.5 | 2.06 | 0.13 |
| RA major diameter (mm) | 44.7 ± 7.2 | 44.1 ± 6.3 | 42.6 ± 5.5 | 40.6 ± 3.1 | 222.7 | 10.3 | < 0.001 |
| RA minor diameter (mm) | 33.9 ± 6.4 | 32.7 ± 5.7 | 31.1 ± 4.0 | 28 ± 2.6 | 1.868 | 13.93 | < 0.001 |
| Myocardial performance index | 55.2 ± 24.4 | 55.8 ± 18.2 | 55 ± 13.5 | 55.1 ± 21 | 1182.9 | 2.797 | 0.067 |
| Fractional area change (%) | 43.2 ± 8.3 | 44.8 ± 7.6 | 46.6 ± 9.2 | 48.1 ± 7.2 | 164.6 | 2.97 | 0.048 |
| Tricuspid annular plane systolic excursion (mm) | 21.8 ± 6.6 | 21.8 ± 5.0 | 22.2 ± 6.6 | 23.1 ± 4.9 | 9.77 | 0.345 | 0.74 |
| Tissue velocity | 12.9 ± 2.1 | 13.7 ± 3.2 | 13.9 ± 3.7 | 14.2 ± 3.9 | 9.91 | 0.92 | 0.40 |
| PAP (mmHg) | 32.7 ± 9.5 | 30.2 ± 6.2 | 27.7 ± 7.7 | 26.4 ± 5.9 | 386.8 | 6.52 | 0.001 |
| RV E/e’ | 7.2 ± 1.15 | 6.5 ± 1.18 | 6.4 ± 2.5 | 6.3 ± 2.0 | 13 | 0.49 | 0.55 |
| RV deceleration time | 175.1 ± 61.5 | 176.8 ± 44.9 | 163.6 ± 36.9 | 169.1 ± 44.3 | 1700.4 | 0.746 | 0.49 |
| TAPSE/PASP | 0.78 ± 0.20 | 0.76 ± 0.20 | 0.86 ± 0.22 | 0.92 ± 0.24 | 0.259 | 5.94 | 0.002 |
| RA volume index | 23.39 ± 7 | 26.20 ± 7.8 | 26.39 ± 4.8 | 24.20 ± 4.8 | 187.2 | 15.2 | 0.000 |
*Adjusted for age, BMI, duration of dialysis, serum creatinine and phosphorus level
Fig. 1The assessment of RV systolic function by 2D STE longitudinal strain in an apical RV view
Fig. 2The linear relationship between RV global longitudinal strain and RV free longitudinal strain changes and time among the participants
Fig. 3The regression line slope of RVGLS changes in hypertensive and non-hypertensive individuals
Fig. 4The slope of the regression line and the actual values of RV global longitudinal strain during the study
Fig. 5The relationship between the basal hemoglobin level and RV global longitudinal strain in individuals under study